Nissha Co.Ltd.

Nissha Co.Ltd.

1,127.00
JPY
+4.00
(+0.36%)
13.58EPS
172.11P/E
98.56BMarket Cap
Nov 11Next Earn
2014 Y
2015 Y
2016 Y
2017 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
2,584.75
2,767.81
2,791.67
2,643.04
- -
4,053.07
3,486.84
3,603.07
3,801.36
3,895.27
3,430.55
4,058.81
4,114.08
- -
Basic EPS, GAAP
92.44
262.04
160.7
-169.08
- -
89.77
-344.27
141.36
318.49
203.64
-61.11
79.91
21.13
- -
Free Cash Flow per Basic Share
-40.83
437.14
233.59
-230.98
- -
-137.52
-136.42
177.25
223.52
119.97
-81.63
86.22
28.67
- -
Dividend per Share
0.14
10
29.92
29.51
- -
30.15
30.03
34.95
30.02
40
60.3
50.3
50.15
- -
Book Value per Share
1,204.09
1,545.22
1,633.39
1,594.66
1,884.64
1,834.49
1,502.72
1,636.88
1,972.87
2,239.63
2,281.64
2,394.01
2,433.54
- -
Tangible Book Value per Share
1,137.05
1,432.98
1,206.36
769.2
1,212.66
1,144.7
837.33
990.31
1,288.94
1,523.65
1,564.07
1,309.83
1,242.87
- -
Basic Weighted Avg Shares
43
43
43
44
48
50
50
50
50
50
49
48
47
47
Sales/Revenue/Turnover
110,922
118,775
119,796
115,802
- -
204,210
174,035
180,006
189,285
193,963
167,726
195,598
194,898
- -
Operating Margin (%)
1.74
7.37
8.8
-3.37
- -
3.51
-9.34
4.07
9.2
4.94
-2.13
2.96
2.26
- -
Depreciation Expense
11,219
9,860
9,087
9,354
- -
10,325
10,074
8,401
9,258
9,487
9,137
9,542
10,360
- -
Net Income, GAAP
3,967
11,245
6,896
-7,408
- -
4,523
-17,183
7,062
15,859
10,140
-2,988
3,851
1,001
- -
Effective Tax Rate (%)
23.01
- -
12.55
- -
- -
33.19
- -
- -
18.76
18.21
- -
35.31
61.05
- -
Profit Margin (%)
3.58
9.47
5.76
-6.4
- -
2.21
-9.87
3.92
8.38
5.23
-1.78
1.97
0.51
- -
Working Capital
3,269
19,676
35,290
12,468
12,887
11,253
4,295
8,362
50,973
67,772
60,809
64,645
35,180
- -
LT Debt
1,397
183
25,120
26,598
22,803
24,309
22,170
17,188
41,750
46,364
46,087
53,915
32,788
- -
Total Equity
51,674
66,311
70,093
74,605
95,672
91,547
75,003
81,924
98,265
111,519
110,853
115,783
117,871
- -
Return on Invested Capital (%)
2.14
- -
9.85
- -
- -
3.51
- -
- -
10.19
4.86
- -
1.97
0.82
- -
Return on Capital (%)
5.85
- -
7.66
- -
- -
4.29
- -
- -
12.28
6.88
- -
2.73
0.72
- -
Return on Common Equity (%)
8.25
19.06
10.11
-10.26
- -
4.84
-20.63
9
17.6
9.66
-2.69
3.42
0.87
- -

Capital Structure

JPY

•

in mil. unless spec.
Mar'24
Jun'24
Mar'26
ST Debt
12,179
19,808
- -
LT Borrowings
37,541
38,095
- -
LT Finance Leases
9,383
9,464
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
48
48
47
Market Capitalization
71,197
98,560
56,849

Working Capital

JPY

•

in mil. unless spec.
Mar'24
Jun'24
Mar'26
Total Current Assets
109,231
124,896
- -
Cash, Cash Equivalents & STI
34,582
45,332
- -
Accounts Receivable, Net
36,648
38,984
- -
Inventories
32,160
35,147
- -
Total Current Liabilities
57,306
69,338
- -
Payables & Accruals
- -
- -
- -
ST Debt
12,179
19,808
- -
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
6.06%
7.82%
1.8%
Free Cash Flow
- -
-91.78%
-67.32%
Net Income, GAAP
- -
-68.77%
-74.01%
Sales/Revenue/Turnover
- -
2.07%
-0.36%
Total Cash Common Dividend
- -
9.42%
-1.98%

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
46,719
52,942
- -
- -
195,598
2025
- -
- -
- -
- -
194,898
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
25.64
64.56
- -
- -
79.91
2025
- -
- -
- -
- -
21.13
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
24.98
0.1
- -
- -
50.3
2025
- -
- -
- -
- -
50.15
2026
- -
- -
- -
- -
- -

Company Description

CEO
Junya Suzuki
Full Time Employees
5,305
Sector
Commercial services
Industry
Commercial printing/Forms
Address
3 Mibu Hanai-cho Kyoto KY Japan 604-8551
IPO Date
Oct 1, 1961
Website
nissha.com
Business
Nissha Co., Ltd. manufactures and sells industrial materials, devices, medical technologies, and related products utilizing core technologies in printing, coating, molding, and metal processing. The company operates through segments including Industrial Materials, offering decorative film-molded parts such as in-mold decoration, in-mold labeling, in-mold electronics, transfer foil, injection molding, metallized paper and board, and sustainable molded products like PaperFoam; Devices, providing touch sensors, force sensors, gas sensors including hydrogen and refrigerant detectors, film heaters, film antennas, and related components; Medical Technologies, encompassing design and manufacturing of single-use medical devices, patient monitoring consumables, disposable ECG electrodes, medical cables, wearables, and minimally invasive surgical devices; as well as Pharmaceuticals and Quasi-drugs, featuring contract development and manufacturing of film-type pharmaceuticals such as oral thin films, transdermal patches, and dissolving microneedle patches, alongside own-brand offerings and services like Re&Go takeout container sharing; Information and Communication, including publication printing, commercial printing, high-definition digital archives, fabric printing, and business media such as industrial recording and ticket/card materials. Nissha maintains a global footprint with operations in Japan, North and South America, Europe, and Asia, including subsidiaries like Nissha USA, Inc., Nissha Medical Technologies, Nissha Europe GmbH, Nissha (Kunshan) Precision IMD Mold Co., Ltd., and Nissha Vietnam Co., Ltd., serving markets in automotive interiors, consumer electronics, healthcare, and pharmaceuticals. Founded in 1929 and headquartered in Kyoto, Japan, the company lists on the Tokyo Stock Exchange Prime Market (7915.T) and employs approximately 5,455 consolidated staff as of June 2025. Recent developments include the acquisition of SHIGAKEN PHARM. IND. CO., LTD., completed in early 2025, marking entry into pharmaceutical contract development and manufacturing organization services for over-the-counter drugs like cold medicines and analgesics across diverse dosage forms and packaging; relocation of engineering operations to Nashville, Tennessee, creating 38 jobs and investing $4.5 million; and a 2023 partnership with Restech to double production of Stretta catheters.